DOSSIET

FDA Approves Biogen’s Drug for Rare Form of ALS

Written by

Rebecca Robbins

in

The drug, which will be sold as Qalsody by the pharmaceutical company Biogen, targets a genetic cause of a devastating neurological illness.

Rebecca Robbins
Author: Rebecca Robbins

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

More posts